Literature DB >> 23210642

TXNDC9 expression in colorectal cancer cells and its influence on colorectal cancer prognosis.

Aiguo Lu1, Xiongzhi Wangpu, Dingpei Han, Hao Feng, Jingkun Zhao, Junjun Ma, Shun Qu, Xuehua Chen, Bingya Liu, Minhua Zheng.   

Abstract

In this study, we analyzed the protein expression of thioredoxin domain containing 9 (TXNDC9) in 116 colorectal cancer (CRC) cases. Among them, 97 were positive in CRC tissues and 60 were positive in normal mucosa. TXNDC9 expression in CRC was correlated with the extent of tumor invasion and the tumor size. TXNDC9-negative patients had longer lifespans. In vitro assays showed the significant suppression of CRC cell proliferation (P < .01) compared with two control groups; the number of invaded cells also decreased (P < .01). These findings suggest that TXNDC9 gene may function in cancer development and may be an effective target for inhibiting the growth and metastasis of CRC cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23210642     DOI: 10.3109/07357907.2012.732160

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  6 in total

1.  Network-Based Enriched Gene Subnetwork Identification: A Game-Theoretic Approach.

Authors:  Abolfazl Razi; Fatemeh Afghah; Salendra Singh; Vinay Varadan
Journal:  Biomed Eng Comput Biol       Date:  2016-04-05

2.  Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.

Authors:  Sang Yeon Cho; Sungha Kim; Mi-Ju Son; Woo Sun Rou; Seok Hyun Kim; Hyuk Soo Eun; Byung Seok Lee
Journal:  Dig Dis Sci       Date:  2018-10-04       Impact factor: 3.199

3.  The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.

Authors:  Xiongzhi Wangpu; Xiao Yang; Jingkun Zhao; Jiaoyang Lu; Shaopei Guan; Jun Lu; Zaklina Kovacevic; Wensheng Liu; Lan Mi; Runsen Jin; Jing Sun; Fei Yue; Junjun Ma; Aiguo Lu; Des R Richardson; Lishun Wang; Minhua Zheng
Journal:  Oncotarget       Date:  2015-10-20

4.  Screening and identification of post-traumatic stress-related serum factors in children with Wilms' tumors.

Authors:  Junjie Zhang; Qian Hu; Fei Guo; Lei Wang; Wei Zhao; D A Zhang; Heying Yang; Jiekai Yu; Lili Niu; Fuquan Yang; Shu Zheng; Jiaxiang Wang
Journal:  Oncol Lett       Date:  2016-01-11       Impact factor: 2.967

5.  TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.

Authors:  Jing Wang; Xiaotao Pan; Jie Li; Jin Zhao
Journal:  Mol Med Rep       Date:  2022-04-29       Impact factor: 2.952

6.  TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.

Authors:  Dawei Chen; Jixue Zou; Zhenguo Zhao; Xiaodong Tang; Zhicheng Deng; Jingchao Jia; Shuanghai Liu
Journal:  Cell Death Dis       Date:  2018-10-31       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.